Article

Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV

2021-10-10

Abstract excerpt

<h4>Summary</h4> <h4>Background</h4> People living with HIV (PLWH) have been reported to have an increased risk of more severe COVID-19 disease outcome and an increased risk of death relative to HIV-uninfected individuals. Here we assessed the ability of the Johnson and Johnson Ad26.CoV2.S vaccine to elicit neutralizing antibodies to the Delta variant in PLWH relative to HIV-uninfected individuals. We also compare...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 93b8ad86-8229-59fe-9746-926739adc84c
DOI: 10.1101/2021.10.08.21264519

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIVDOI 10.1101/2021.10.08.21264519Read

Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV-1Semantic proximity Read

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine in People Living with HIV-1Semantic proximity Read

Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIVSemantic proximity Read

Effectiveness of the Ad26.Cov2.S Vaccine in Health Care Workers in South AfricaSemantic proximity Read

Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 VariantSemantic proximity Read

Immunogenicity and Safety of Inactivated SARS-CoV-2 Vaccine in People Living with HIV: A Cross-Sectional StudySemantic proximity Read

SARS-CoV-2 mRNA Vaccine Induced Immune Responses in Men with HIV-1 and Impact on Proviral ReservoirsSemantic proximity Read

POST-ACUTE SEQUELAE AND ADAPTIVE IMMUNE RESPONSES IN PEOPLE LIVING WITH HIV RECOVERING FROM SARS-COV-2 INFECTIONSemantic proximity Read

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIVSemantic proximity Read

Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concernSemantic proximity Read

Effectiveness of the Single-Dose Ad26.COV2.S COVID VaccineSemantic proximity Read

SARS-CoV-2 evolved during advanced HIV disease immunosuppression has Beta-like escape of vaccine and Delta infection elicited immunitySemantic proximity Read